• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Fabesetron

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5799296

Fabesetron (FK1052) is an orally active 5-HT 3 receptor antagonist with 5-HT 4 receptor antagonistic activity. Fabesetron (FK1052) can be used in the study for both acute and delayed emesis induced by cancer chemotherapy. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Fabesetron, Biochemical
Full Product Name
Fabesetron
Purity/Purification
98%
Preparation and Storage
Powder: -20 degree C for 3 years
In solvent: -80 degree C for 2 years
CAS
129300-27-2
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
In vitro
Fabesetron (FK1052)(0.1 mg/kg p.o.) inhibits completely the increases in the colonic transit[1]. FK1052 (100 ug/kg) completely prevents emesis induced by cisplatin (18mg/kg, i.p.) in Suncus murinus[2]. Animal Model: Male Sprague-Dawley rats weighing 220 to 330 g and male ddy mice weighing 25 to 35 g were used[1]. Dosage: 0.1 mg/kg. Administration: P.O. Result: Significantly caused delay and its degree of inhibition was 33.8 +/- 4.8% by 0.1 mg/kg p.o. Animal Model: Suncus murinus of either sex (10-week-old; 30-70 g body weight)[2]. Dosage: 1, 10, and 100 ug/kg. Administration: Orally administered 30 min before the injection of cisplatin. Result: Inhibited cisplatininduced emesis in a dose-dependent manner, and no emesis was observed in three animals given the compound at 100 ug/kg.

Structure of Fabesetron biochemical

L-803087 TFA, CAS 1786412-46-1
Fabesetron Biochemical – Cat# MBS5799296

Structure of Fabesetron biochemical

L-803087 TFA, CAS 1786412-46-1
Fabesetron Biochemical, Structure – Cat# MBS5799296

Product References and Citations for Fabesetron biochemical

1. Rohrer SP, et al. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science. 1998 Oct 23;282(5389):737-40.
2. Moneta D, et al. Somatostatin receptor subtypes 2 and 4 affect seizure susceptibility and hippocampal excitatory neurotransmission in mice. Eur J Neurosci. 2002 Sep;16(5):843-9.

Other Notes

Small volumes of Fabesetron biochemical vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Fabesetron purchase

MBS5799296 is a biochemical targeting Fabesetron.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000